MRI reveals how MitraClip reshapes the heart
NCT ID NCT02924363
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looked at 54 people with severe mitral regurgitation who received the MitraClip device. Researchers used heart MRI and ultrasound before, right after, and 6 months after the procedure to see how the heart's shape and function changed. The goal was to understand the heart's remodeling process, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- MitraClip device
- What this could lead to
- If successful, this study could help doctors understand how MitraClip repairs the heart's shape and function, guiding better treatment for mitral regurgitation.
- What could go wrong
- This is a small, completed observational study (54 people) that measures changes but does not test a new treatment or prove long-term benefits. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Piedmont Heart Institute
Atlanta, Georgia, 30309, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Can a new valve device fix a leaky heart without open surgery?
- Can mixed reality make heart valve surgery safer and faster?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- New heart valve device could spare High-Risk patients from Open-Heart surgery
- First-in-Human trial aims to offer new hope for patients with leaky heart valves who Can't have surgery